T Cell Receptors Targeting Defective DNA Repair Proteins

Search text
Active Filters
Liver cancer
About 1 result
(0.07 seconds)
Scientists from University of Pittsburgh have developed a novel approach to target cancer cells through the insertion of a “suicide gene” (HSV1-tk) into key gene fusion areas of the cancer genome.
• Creation of this unique breakpoint, present only in cancer tissue provides a target for therapeutic intervention which is less likely to result in drug resistance through gene mutation.
Scientists from University of Pittsburgh have developed a novel approach to target cancer cells through the insertion of a “suicide gene” (HSV1-tk) into key gene fusion areas of the cancer genome.
    • Technology Type
      • 1
        Therapeutic Modality
      • Add ...
    • Technology Subtype
      • 1
        Gene Therapy - CRISPR
      • Add ...
    • Therapeutic Areas
      • 1
        Oncology
      • Add ...
    • Therapeutic Indications
      • 4
        Breast cancer
      • 4
        Leukemia
      • 4
        Solid tumor
      • 2
        Other
      • 2
        Skin cancer
      • 1
        Liver cancer
      • Add ...
    • Tags
      • Add ...
    • Lead Inventor
      • 1
        Jianhua Luo
      • Add ...
    • Department
      • 1
        Med-Pathology
      • Add ...
    • All Tech Innovators
      • 1
        Baoguo Ren
      • 1
        Jianhua Luo
      • 1
        Junyan Tao
      • 1
        Muhamuda Kader
      • 1
        Satdarshan Pal Singh Monga
      • Add ...
    • Date Submitted
This site uses cookies to deliver a better user experience. Learn more.